{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:49:36Z","timestamp":1791946176503,"version":"4.3.4"},"reference-count":340,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T00:00:00Z","timestamp":1449619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"publisher","award":["P26112-B19,"],"award-info":[{"award-number":["P26112-B19,"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"publisher","award":["P24843-B24"],"award-info":[{"award-number":["P24843-B24"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund (FWF)","doi-asserted-by":"publisher","award":["I2738-B26"],"award-info":[{"award-number":["I2738-B26"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.bbamcr.2015.12.005","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T21:31:36Z","timestamp":1450301496000},"page":"934-955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Peroxisomes in brain development and function"],"prefix":"10.1016","volume":"1863","author":[{"given":"Johannes","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Dorninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Forss-Petter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.bbamcr.2015.12.005_bb0005","first-page":"1","article-title":"Microbodies and related particles. Morphology, biochemistry, and physiology","author":"Hruban","year":"1969","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0010","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1074\/mcp.M700169-MCP200","article-title":"Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling","volume":"6","author":"Wiese","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.biochem.74.082803.133329","article-title":"Biochemistry of mammalian peroxisomes revisited","volume":"75","author":"Wanders","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0020","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbadis.2012.04.006","article-title":"Genetics and molecular basis of human peroxisome biogenesis disorders","volume":"1822","author":"Waterham","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0025","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/pmic.200600638","article-title":"Quantitative proteomic comparison of mouse peroxisomes from liver and kidney","volume":"7","author":"Mi","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1750-3639.1998.tb00139.x","article-title":"Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis","volume":"8","author":"Powers","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0035","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1194\/jlr.R005959","article-title":"Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism","volume":"51","author":"Van Veldhoven","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbadis.2011.12.001","article-title":"Role of peroxisomes in ROS\/RNS-metabolism: implications for human disease","volume":"1822","author":"Fransen","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0045","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bbadis.2011.12.011","article-title":"Transfer of metabolites across the peroxisomal membrane","volume":"1822","author":"Antonenkov","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bbadis.2012.03.004","article-title":"Primary hyperoxalurias: disorders of glyoxylate detoxification","volume":"1822","author":"Salido","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"Dyall","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0060","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/27.3.39097","article-title":"Ultrastructural localization of D-amino acid oxidase in microperoxisomes of the rat nervous system","volume":"27","author":"Arnold","year":"1979","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0070","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.febslet.2011.05.032","article-title":"A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity","volume":"585","author":"Kassmann","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0006-8993(91)90314-L","article-title":"Developmental immunohistochemistry of catalase in the human brain","volume":"556","author":"Houdou","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/nbdi.1997.0127","article-title":"Expression of the adrenoleukodystrophy protein in the human and mouse central nervous system","volume":"3","author":"Fouquet","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/21.4.349","article-title":"Notes on synaptic vesicles and related structures, endoplasmic reticulum, lysosomes and peroxisomes in nervous tissue and the adrenal medulla","volume":"21","author":"Holtzman","year":"1973","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1007563201595","article-title":"Isolation and biochemical characterization of peroxisomes from cultured rat glial cells","volume":"25","author":"Singh","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.21448","article-title":"Differential expression of peroxisomal matrix and membrane proteins during postnatal development of mouse brain","volume":"505","author":"Ahlemeyer","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1177\/002215549904701001","article-title":"Current cytochemical techniques for the investigation of peroxisomes. A review","volume":"47","author":"Fahimi","year":"1999","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbagen.2004.01.004","article-title":"Peroxisomal localization in the developing mouse cerebellum: implications for neuronal abnormalities related to deficiencies in peroxisomes","volume":"1671","author":"Nagase","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(78)90300-1","article-title":"Microperoxisomes in the central nervous system of the postnatal rat","volume":"155","author":"Arnold","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03160002","article-title":"Immunohistochemical expression of peroxisomal enzymes in developing human brain","volume":"19","author":"Houdou","year":"1993","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0736-5748(86)90003-1","article-title":"A possible relationship between concentration of microperoxisomes and myelination","volume":"4","author":"Adamo","year":"1986","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0125","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1046\/j.0014-2956.2001.02409.x","article-title":"Purification of brain peroxisomes and localization of 3-hydroxy-3-methylglutaryl coenzyme A reductase","volume":"268","author":"Kovacs","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0169-328X(99)00252-1","article-title":"Gene expression of peroxisomal beta-oxidation enzymes in rat brain","volume":"74","author":"Knoll","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1042\/bj3530673","article-title":"Prenatal and postnatal development of peroxisomal lipid-metabolizing pathways in the mouse","volume":"353","author":"Huyghe","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0140","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1432-1327.1999.00772.x","article-title":"The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression","volume":"265","author":"Berger","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0145","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/21.1.34","article-title":"Peroxisomes in dorsal root ganglia","volume":"21","author":"Citkowitz","year":"1973","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2007.07.007","article-title":"Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy","volume":"28","author":"Hoftberger","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.biochi.2013.09.009","article-title":"Brain peroxisomes","volume":"98","author":"Trompier","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fcell.2015.00035","article-title":"Redox interplay between mitochondria and peroxisomes","volume":"3","author":"Lismont","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0165","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.freeradbiomed.2013.08.173","article-title":"Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells","volume":"65","author":"Wang","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/db09-1401","article-title":"Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells","volume":"60","author":"Elsner","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0175","doi-asserted-by":"crossref","first-page":"623257","DOI":"10.1155\/2012\/623257","article-title":"Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E)","volume":"2012","author":"Zarrouk","year":"2012","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0180","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.1074\/jbc.273.25.15639","article-title":"Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism","volume":"273","author":"Fan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00593330","article-title":"The MR spectrum of peroxisomal disorders","volume":"33","author":"van der Knaap","year":"1991","journal-title":"Neuroradiology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0190","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2371","article-title":"Acatalasemia","author":"Eaton","year":"1995"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0195","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0531-5565(98)00014-X","article-title":"The biological significance of plasmalogens in defense against oxidative damage","volume":"33","author":"Brosche","year":"1998","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0200","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/hmg\/dds097","article-title":"Impaired neurotransmission in ether lipid-deficient nerve terminals","volume":"21","author":"Brodde","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0205","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2174\/092986709788682164","article-title":"Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis","volume":"16","author":"Lessig","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.chemphyslip.2011.06.008","article-title":"Plasmalogens the neglected regulatory and scavenging lipid species","volume":"164","author":"Wallner","year":"2011","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.biochi.2013.09.012","article-title":"Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy","volume":"98","author":"Fourcade","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0220","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0225","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.bbamcr.2006.09.010","article-title":"Peroxisome biogenesis disorders","volume":"1763","author":"Steinberg","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0230","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1546315","article-title":"A human gene responsible for Zellweger syndrome that affects peroxisome assembly","volume":"255","author":"Shimozawa","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0235","article-title":"Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood","author":"Berendse","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0240","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/01.WNL.0000106943.40848.03","article-title":"Neuroimaging of peroxisome biogenesis disorders (Zellweger spectrum) with prolonged survival","volume":"62","author":"Barth","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00686900","article-title":"Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration","volume":"20","author":"Volpe","year":"1972","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00689761","article-title":"The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis","volume":"41","author":"Evrard","year":"1978","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0255","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ajmg.1320230404","article-title":"Neonatal adrenoleukodystrophy: new cases, biochemical studies, and differentiation from Zellweger and related peroxisomal polydystrophy syndromes","volume":"23","author":"Kelley","year":"1986","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0260","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00005072-199509000-00014","article-title":"The pathology of peroxisomal disorders with pathogenetic considerations","volume":"54","author":"Powers","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0265","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s10545-008-0856-3","article-title":"Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients","volume":"31","author":"Weller","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0270","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbadis.2012.03.011","article-title":"Clinical diagnosis, biochemical findings and MRI spectrum of peroxisomal disorders","volume":"1822","author":"Poll-The","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0275","first-page":"1163","article-title":"MR of Zellweger syndrome","volume":"18","author":"Barkovich","year":"1997","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1073858409336297","article-title":"Peroxisomes, myelination, and axonal integrity in the CNS","volume":"15","author":"Baes","year":"2009","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jnnp.49.1.77","article-title":"Neonatal adrenoleukodystrophy","volume":"49","author":"Aubourg","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0290","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jmg.2009.074302","article-title":"Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene","volume":"47","author":"Ebberink","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-6-8","article-title":"Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene","volume":"6","author":"Sevin","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0300","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0997-49","article-title":"A mouse model for Zellweger syndrome","volume":"17","author":"Baes","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0305","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.139.5.1293","article-title":"Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder","volume":"139","author":"Faust","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0310","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1128\/MCB.23.16.5947-5957.2003","article-title":"Pex13 inactivation in the mouse disrupts peroxisome biogenesis and leads to a Zellweger syndrome phenotype","volume":"23","author":"Maxwell","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0315","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ymgme.2014.01.008","article-title":"The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder","volume":"111","author":"Hiebler","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0320","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1128\/MCB.22.23.8226-8240.2002","article-title":"PEX11alpha is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0325","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1128\/MCB.22.12.4358-4365.2002","article-title":"PEX11 beta deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function","volume":"22","author":"Li","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0330","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/JMN:16:2-3:289","article-title":"The peroxisome deficient PEX2 Zellweger mouse: pathologic and biochemical correlates of lipid dysfunction","volume":"16","author":"Faust","year":"2001","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0335","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.21532","article-title":"Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice","volume":"45","author":"Keane","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0340","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/cne.10699","article-title":"Abnormal cerebellar histogenesis in PEX2 Zellweger mice reflects multiple neuronal defects induced by peroxisome deficiency","volume":"461","author":"Faust","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0345","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10545-005-7059-y","article-title":"Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain","volume":"28","author":"Faust","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0350","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1242\/jcs.064907","article-title":"PEX11 family members are membrane elongation factors that coordinate peroxisome proliferation and maintenance","volume":"123","author":"Koch","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0355","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1523\/JNEUROSCI.4968-07.2008","article-title":"Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration","volume":"28","author":"Hulshagen","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0360","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jnr.21097","article-title":"Neocortical and cerebellar developmental abnormalities in conditions of selective elimination of peroxisomes from brain or from liver","volume":"85","author":"Krysko","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0365","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1742-2094-9-61","article-title":"Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system","volume":"9","author":"Bottelbergs","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0370","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1242\/dmm.004622","article-title":"PEX13 deficiency in mouse brain as a model of Zellweger syndrome: abnormal cerebellum formation, reactive gliosis and oxidative stress","volume":"4","author":"Muller","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0375","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/ng2070","article-title":"Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes","volume":"39","author":"Kassmann","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0380","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.21027","article-title":"Axonal integrity in the absence of functional peroxisomes from projection neurons and astrocytes","volume":"58","author":"Bottelbergs","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0385","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1523\/JNEUROSCI.23-30-09732.2003","article-title":"Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues","volume":"23","author":"Janssen","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0390","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/hmg\/ddh107","article-title":"A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids","volume":"13","author":"Savolainen","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0395","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/humu.20535","article-title":"Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency","volume":"28","author":"Ferdinandusse","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2015.06.018","article-title":"Role of peroxisomes in human lipid metabolism and its importance for neurological development","author":"Wanders","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0405","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.2009.176255","article-title":"Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy","volume":"81","author":"Ferdinandusse","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0410","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1749-6632.1996.tb18643.x","article-title":"Targeted disruption of the peroxisomal fatty acyl-CoA oxidase gene: generation of a mouse model of pseudoneonatal adrenoleukodystrophy","volume":"804","author":"Fan","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0415","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.20702","article-title":"Clinical and biochemical spectrum of D-bifunctional protein deficiency","volume":"59","author":"Ferdinandusse","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1086\/498880","article-title":"Mutational spectrum of D-bifunctional protein deficiency and structure-based genotype\u2013phenotype analysis","volume":"78","author":"Ferdinandusse","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0425","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajhg.2010.07.007","article-title":"Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome","volume":"87","author":"Pierce","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0430","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ajmg.a.20616","article-title":"Perrault syndrome: evidence for progressive nervous system involvement","volume":"128A","author":"Fiumara","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0435","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00234-010-0768-4","article-title":"Neurodegeneration in D-bifunctional protein deficiency: diagnostic clues and natural history using serial magnetic resonance imaging","volume":"52","author":"Khan","year":"2010","journal-title":"Neuroradiology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0440","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-7-90","article-title":"Specific combination of compound heterozygous mutations in 17beta-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency","volume":"7","author":"McMillan","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0445","doi-asserted-by":"crossref","first-page":"16329","DOI":"10.1074\/jbc.M001994200","article-title":"Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids","volume":"275","author":"Baes","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0450","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1210\/en.2005-1571","article-title":"Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice","volume":"147","author":"Huyghe","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0455","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gene.10047","article-title":"Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomes","volume":"32","author":"Baes","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0460","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2353\/ajpath.2006.041220","article-title":"Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system","volume":"168","author":"Huyghe","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0465","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/72861","article-title":"Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy","volume":"24","author":"Ferdinandusse","year":"2000","journal-title":"Nat. Genet."},{"issue":"Suppl. 3","key":"10.1016\/j.bbamcr.2015.12.005_bb0470","doi-asserted-by":"crossref","first-page":"S349","DOI":"10.1007\/s10545-010-9183-6","article-title":"An adult onset case of alpha-methyl-acyl-CoA racemase deficiency","volume":"33","author":"Smith","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0475","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0b013e31821a4484","article-title":"AMACR mutations cause late-onset autosomal recessive cerebellar ataxia","volume":"76","author":"Dick","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0480","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/01.WNL.0000132841.81250.B7","article-title":"Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency","volume":"63","author":"Clarke","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0485","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp.2007.129478","article-title":"Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency","volume":"79","author":"Thompson","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-1","article-title":"MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing","volume":"8","author":"Haugarvoll","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0495","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/gast.2003.50017","article-title":"Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy","volume":"124","author":"Setchell","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0500","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bbalip.2013.05.002","article-title":"Metabolic adaptation allows Amacr-deficient mice to remain symptom-free despite low levels of mature bile acids","volume":"1831","author":"Selkala","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0505","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.bbalip.2015.07.008","article-title":"Phytol is lethal for Amacr-deficient mice","volume":"1851","author":"Selkala","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0510","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1086\/503921","article-title":"Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy","volume":"78","author":"Ferdinandusse","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0515","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.biochi.2004.09.028","article-title":"Targeted disruption of the peroxisomal thiolase B gene in mouse: a new model to study disorders related to peroxisomal lipid metabolism","volume":"86","author":"Chevillard","year":"2004","journal-title":"Biochimie"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0520","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1101\/gad.12.8.1189","article-title":"Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2\/sterol carrier protein-x gene function","volume":"12","author":"Seedorf","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0525","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0171-9335(98)80121-0","article-title":"Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines","volume":"75","author":"Troffer-Charlier","year":"1998","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0530","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1373\/49.2.230","article-title":"Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues","volume":"49","author":"Langmann","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0535","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/hmg\/ddt645","article-title":"X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes","volume":"23","author":"Weber","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0540","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","article-title":"Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters","volume":"361","author":"Mosser","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0545","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening","volume":"49","author":"Bezman","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0550","first-page":"109","article-title":"The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis","volume":"8","author":"Wiesinger","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0555","doi-asserted-by":"crossref","first-page":"19269","DOI":"10.1074\/jbc.M112.445445","article-title":"Impaired very long-chain acyl-CoA beta-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction","volume":"288","author":"Wiesinger","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0560","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1096\/fj.08-110866","article-title":"The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters","volume":"22","author":"van Roermund","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0565","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbalip.2013.12.001","article-title":"A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids","volume":"1841","author":"van Roermund","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0570","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/3242","article-title":"Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy","volume":"4","author":"Kemp","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0575","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/hmg\/8.5.907","article-title":"Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy","volume":"8","author":"Netik","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0580","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/emmm.201000061","article-title":"The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy","volume":"2","author":"Ofman","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0585","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbalip.2014.12.005","article-title":"Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesis","volume":"1851","author":"Schackmann","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0590","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.plipres.2006.01.004","article-title":"Fatty acid elongases in mammals: Their regulation and roles in metabolism","volume":"45","author":"Jakobsson","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0595","doi-asserted-by":"crossref","first-page":"18439","DOI":"10.1073\/pnas.1005572107","article-title":"ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis","volume":"107","author":"Ohno","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2012.03.012","article-title":"X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects","author":"Kemp","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0605","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1006\/bbrc.1994.2855","article-title":"X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes","volume":"205","author":"Berger","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0610","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bbamcr.2006.07.010","article-title":"X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects","volume":"1763","author":"Berger","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0615","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.biochi.2013.11.023","article-title":"Pathophysiology of X-linked adrenoleukodystrophy","volume":"98","author":"Berger","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0620","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.56.3.273","article-title":"Mutational analysis and the pathogenesis of variant X-linked adrenoleukodystrophy phenotypes","volume":"56","author":"Moser","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0625","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/humu.1227","article-title":"ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations","volume":"18","author":"Kemp","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0630","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2004.10.067","article-title":"Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening","volume":"146","author":"Dubey","year":"2005","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0635","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jnen\/60.5.493","article-title":"The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria","volume":"60","author":"Powers","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0640","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/01.WNL.0000149514.13580.84","article-title":"Spectroscopic evidence of cerebral axonopathy in patients with \u201cpure\u201d adrenomyeloneuropathy","volume":"64","author":"Dubey","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0645","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1212\/WNL.46.1.112","article-title":"Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study","volume":"46","author":"van Geel","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0650","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awt361","article-title":"X-linked adrenoleukodystrophy in women: a cross-sectional cohort study","volume":"137","author":"Engelen","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0655","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awu232","article-title":"Age-dependent penetrance among females with X-linked adrenoleukodystrophy","volume":"138","author":"Horn","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0660","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00401-004-0961-9","article-title":"Adreno-leukodystrophy: a personal historical note","volume":"109","author":"Powers","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0665","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/hmg\/ddn066","article-title":"Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture","volume":"17","author":"Hein","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0670","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1750-1172-7-51","article-title":"X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management","volume":"7","author":"Engelen","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0675","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410400221","article-title":"Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype","volume":"40","author":"Korenke","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0680","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.1220","article-title":"Monozygotic twins with X-linked adrenoleukodystrophy and different phenotypes","volume":"50","author":"Di Rocco","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0685","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1750-3639.2010.00393.x","article-title":"Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy","volume":"20","author":"Berger","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0690","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2009.11.005","article-title":"Head trauma can initiate the onset of adreno-leukodystrophy","volume":"290","author":"Raymond","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0695","article-title":"Intensity of MRI gadolinium enhancement in cerebral adrenoleukodystrophy: a biomarker for inflammation and predictor of outcome following transplantation in higher risk patients","author":"Miller","year":"2015","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0700","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jnen\/60.10.1004","article-title":"Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation","volume":"60","author":"Ito","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0705","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2003.08.013","article-title":"Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies","volume":"14","author":"Paintlia","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0710","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","article-title":"Adreno-leukodystrophy: oxidative stress of mice and men","volume":"64","author":"Powers","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0715","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00005072-199211000-00007","article-title":"The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications","volume":"51","author":"Powers","year":"1992","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0720","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.21391","article-title":"Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?","volume":"63","author":"Eichler","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0725","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0730","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation","volume":"322","author":"Aubourg","year":"1990","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0735","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0740","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1750-3639.2010.00394.x","article-title":"Hematopoietic stem cell transplantation and hematopoietic stem cell gene therapy in X-linked adrenoleukodystrophy","volume":"20","author":"Cartier","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0745","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/hmg\/ddr536","article-title":"Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy","volume":"21","author":"Schluter","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0750","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv250","article-title":"Brain endothelial dysfunction in cerebral adrenoleukodystrophy","author":"Musolino","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0755","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W","article-title":"Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice","volume":"50","author":"Forss-Petter","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0760","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1073\/pnas.94.17.9366","article-title":"A mouse model for X-linked adrenoleukodystrophy","volume":"94","author":"Lu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0765","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/bbrc.1997.6340","article-title":"Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism","volume":"232","author":"Kobayashi","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0770","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/hmg\/11.5.499","article-title":"Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy","volume":"11","author":"Pujol","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0775","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00401-007-0288-4","article-title":"Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1\/Mag deficiency","volume":"114","author":"Dumser","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0780","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/hmg\/ddh323","article-title":"Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy","volume":"13","author":"Pujol","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108655","article-title":"Abcd2 Is a strong modifier of the metabolic impairments in peritoneal macrophages of Abcd1-deficient mice","volume":"9","author":"Muneer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0790","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/hmg\/ddi125","article-title":"Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency","volume":"14","author":"Oezen","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0795","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bbadis.2012.02.005","article-title":"Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?","volume":"1822","author":"Galea","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0800","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/hmg\/ddn085","article-title":"Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy","volume":"17","author":"Fourcade","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0805","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbadis.2003.10.004","article-title":"Evidence that oxidative stress is increased in patients with X-linked adrenoleukodystrophy","volume":"1688","author":"Vargas","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0810","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ymgme.2013.05.009","article-title":"Glutathione imbalance in patients with X-linked adrenoleukodystrophy","volume":"109","author":"Petrillo","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0815","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.22363","article-title":"Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy","volume":"70","author":"Lopez-Erauskin","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0820","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awt143","article-title":"Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy","volume":"136","author":"Morato","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0825","first-page":"36-36","article-title":"Oligodendrocytes and Schwann cells support axon function and survival independent of their role in myelination: implications for multiple sclerosis","volume":"178","author":"Nave","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0830","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/WCO.0b013e328300c71f","article-title":"Oligodendroglial impact on axonal function and survival\u2014a hypothesis","volume":"21","author":"Kassmann","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0835","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ng1095","article-title":"Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination","volume":"33","author":"Lappe-Siefke","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0840","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1126\/science.280.5369.1610","article-title":"Axonal swellings and degeneration in mice lacking the major proteolipid of myelin","volume":"280","author":"Griffiths","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0845","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbalip.2011.06.006","article-title":"Phytanic acid metabolism in health and disease","volume":"1811","author":"Wanders","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0850","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ng1097-190","article-title":"Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene","volume":"17","author":"Jansen","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0855","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/hmg\/9.8.1195","article-title":"Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum's disease","volume":"9","author":"Jansen","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0860","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3303","article-title":"Refsum disease","author":"Wanders","year":"2001"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0865","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp.2008.161059","article-title":"The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease","volume":"81","author":"Baldwin","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0870","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.survophthal.2010.03.007","article-title":"Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy","volume":"55","author":"Ruether","year":"2010","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0875","doi-asserted-by":"crossref","first-page":"17712","DOI":"10.1073\/pnas.0806066105","article-title":"Ataxia with loss of Purkinje cells in a mouse model for Refsum disease","volume":"105","author":"Ferdinandusse","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0880","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ng0497-369","article-title":"Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata","volume":"15","author":"Braverman","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0885","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng0497-377","article-title":"Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor","volume":"15","author":"Motley","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0890","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng0497-381","article-title":"Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor","volume":"15","author":"Purdue","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0895","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02435984","article-title":"Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder","volume":"15","author":"Wanders","year":"1992","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0900","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00711817","article-title":"Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder","volume":"17","author":"Wanders","year":"1994","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0905","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1212\/01.wnl.0000255960.01644.39","article-title":"Phenotype of adult Refsum disease due to a defect in peroxin 7","volume":"68","author":"Horn","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0910","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3988\/jcn.2015.11.2.197","article-title":"PEX7 mutations cause congenital cataract retinopathy and late-onset ataxia and cognitive impairment: report of two siblings and review of the literature","volume":"11","author":"Nanetti","year":"2015","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0915","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajhg.2014.10.003","article-title":"A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency","volume":"95","author":"Buchert","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0920","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1074\/jbc.M114.601575","article-title":"Mechanistic insights into PTS2-mediated peroxisomal protein import: the co-receptor PEX5L drastically increases the interaction strength between the cargo protein and the receptor PEX7","volume":"290","author":"Kunze","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0925","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1093\/hmg\/ddv305","article-title":"A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform","volume":"24","author":"Baroy","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0930","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0022-3476(88)80689-9","article-title":"Biochemical abnormalities in rhizomelic chondrodysplasia punctata","volume":"112","author":"Hoefler","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0935","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0940","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/jhg.2014.39","article-title":"Mild reduction of plasmalogens causes rhizomelic chondrodysplasia punctata: functional characterization of a novel mutation","volume":"59","author":"Noguchi","year":"2014","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0945","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00735395","article-title":"Chondrodysplasia punctata with a mild clinical course","volume":"17","author":"Nuoffer","year":"1994","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0950","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/humu.10124","article-title":"Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype","volume":"20","author":"Braverman","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0955","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1750-1172-8-174","article-title":"The neurology of rhizomelic chondrodysplasia punctata","volume":"8","author":"Bams-Mengerink","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0960","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ajmg.a.20009","article-title":"Natural history of rhizomelic chondrodysplasia punctata","volume":"118A","author":"White","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0965","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1086\/338998","article-title":"Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1","volume":"70","author":"Motley","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0970","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01811703","article-title":"A new type of chondrodysplasia punctata associated with peroxisomal dysfunction","volume":"14","author":"Poll-The","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0975","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/01.wnl.0000205594.34647.d0","article-title":"MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata","volume":"66","author":"Bams-Mengerink","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0980","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0012162200000918","article-title":"Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency)","volume":"42","author":"Sztriha","year":"2000","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0985","doi-asserted-by":"crossref","first-page":"879679","DOI":"10.1155\/2014\/879679","article-title":"A case of rhizomelic chondrodysplasia punctata in newborn","volume":"2014","author":"Karabayir","year":"2014","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0990","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/pd.1970140821","article-title":"Prenatal ultrasound diagnosis of rhizomelic chondrodysplasia punctata in a primigravida","volume":"14","author":"Sastrowijoto","year":"1994","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb0995","first-page":"480","article-title":"MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata","volume":"23","author":"Viola","year":"2002","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1000","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pediatrneurol.2007.07.006","article-title":"Neuroimaging features in a neonate with rhizomelic chondrodysplasia punctata","volume":"37","author":"Goh","year":"2007","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/346093","article-title":"Identification of PEX7 as the second gene involved in Refsum disease","volume":"72","author":"van den Brink","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s004010051060","article-title":"Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: a potential role for phytanic acid and calcium in the death of its Purkinje cells","volume":"98","author":"Powers","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/humu.21623","article-title":"Functional characterization of novel mutations in GNPAT and AGPS, causing rhizomelic chondrodysplasia punctata (RCDP) types 2 and 3","volume":"33","author":"Itzkovitz","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1020","first-page":"190","article-title":"Heterogeneity of Chondrodysplasia punctata","volume":"11","author":"Spranger","year":"1971","journal-title":"Humangenetik"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1025","first-page":"62","article-title":"Calcareous chondropathies in the newborn infant","volume":"57","author":"Yakovac","year":"1954","journal-title":"AMA Arch. Pathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3476(88)80378-0","article-title":"Rhizomelic chondrodysplasia punctata: clinical, pathologic, and biochemical findings in two patients","volume":"113","author":"Poulos","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/1096-8628(20010215)99:1<63::AID-AJMG1117>3.0.CO;2-9","article-title":"Cervical stenosis secondary to rhizomelic chondrodysplasia punctata","volume":"99","author":"Khanna","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/15513819509026986","article-title":"Rhizomelic chondrodysplasia punctata: report of a case with review of the literature and correlation with other peroxisomal disorders","volume":"15","author":"Agamanolis","year":"1995","journal-title":"Pediatr. Pathol. Lab. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0730-725X(02)00625-2","article-title":"Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings","volume":"21","author":"Alkan","year":"2003","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1050","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/hmg\/ddg236","article-title":"Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata","volume":"12","author":"Brites","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1055","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/hmg\/ddg191","article-title":"Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice","volume":"12","author":"Rodemer","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgmr.2014.06.003","article-title":"Alkylglycerone phosphate synthase (AGPS) deficient mice: models for rhizomelic chondrodysplasia punctate type 3 (RCDP3) malformation syndrome","volume":"1","author":"Liegel","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cmet.2012.06.013","article-title":"Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity","volume":"16","author":"Lodhi","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2014.12.002","article-title":"Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability","volume":"21","author":"Lodhi","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ymgme.2009.12.005","article-title":"A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton","volume":"99","author":"Braverman","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2011.02.002","article-title":"Blind sterile 2 (bs2), a hypomorphic mutation in Agps, results in cataracts and male sterility in mice","volume":"103","author":"Liegel","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1085","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbamcr.2006.08.038","article-title":"The ether lipid-deficient mouse: tracking down plasmalogen functions","volume":"1763","author":"Gorgas","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1090","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddp110","article-title":"Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum","volume":"18","author":"Teigler","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1095","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1172\/JCI72063","article-title":"Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination","volume":"124","author":"da Silva","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/brain\/awn295","article-title":"Plasmalogens participate in very-long-chain fatty acid-induced pathology","volume":"132","author":"Brites","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1742-2094-9-197","article-title":"Anti-inflammatory\/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice","volume":"9","author":"Ifuku","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.2012.06641.x","article-title":"Effects of plasmalogens on systemic lipopolysaccharide-induced glial activation and beta-amyloid accumulation in adult mice","volume":"1262","author":"Katafuchi","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1115","doi-asserted-by":"crossref","first-page":"61012","DOI":"10.1039\/C5RA00632E","article-title":"Extrinsic plasmalogens suppress neuronal apoptosis in mouse neuroblastoma Neuro-2A cells: importance of plasmalogen molecular species","volume":"5","author":"Yamashita","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083508","article-title":"Plasmalogens rescue neuronal cell death through an activation of AKT and ERK survival signaling","volume":"8","author":"Hossain","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymgme.2010.02.003","article-title":"Combined deficiency of peroxisomal beta-oxidation and ether lipid synthesis in mice causes only minor cortical neuronal migration defects but severe hypotonia","volume":"100","author":"Krysko","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1130","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bpa.12290","article-title":"Peroxisomal Disorders: A Review on Cerebellar Pathologies","volume":"25","author":"De Munter","year":"2015","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1135","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.bbadis.2012.05.014","article-title":"The importance of ether-phospholipids: a view from the perspective of mouse models","volume":"1822","author":"da Silva","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1140","doi-asserted-by":"crossref","first-page":"45048","DOI":"10.1074\/jbc.M111.301853","article-title":"Structural requirements for interaction of peroxisomal targeting signal 2 and its receptor PEX7","volume":"286","author":"Kunze","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101076","article-title":"Involvement of plasmalogens in post-natal retinal vascular development","volume":"9","author":"Saab","year":"2014","journal-title":"PLoS One"},{"issue":"Pt A","key":"10.1016\/j.bbamcr.2015.12.005_bb1150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biochi.2014.07.023","article-title":"Plasmalogens in the retina: from occurrence in retinal cell membranes to potential involvement in pathophysiology of retinal diseases","volume":"107","author":"Saab","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1155","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.freeradbiomed.2015.03.012","article-title":"Plasmalogen phospholipids protect internodal myelin from oxidative damage","volume":"84","author":"Luoma","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbalip.2014.11.005","article-title":"Homeostasis of phospholipids\u2014the level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens","volume":"1851","author":"Dorninger","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1165","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/bi00185a019","article-title":"Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion","volume":"33","author":"Glaser","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/hmg\/10.2.127","article-title":"Impaired membrane traffic in defective ether lipid biosynthesis","volume":"10","author":"Thai","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0005-2736(89)90510-5","article-title":"Influence of plasmalogen deficiency on membrane fluidity of human skin fibroblasts: a fluorescence anisotropy study","volume":"978","author":"Hermetter","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1180","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.E600002-JLR200","article-title":"Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function","volume":"47","author":"Pike","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1185","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1190","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1021\/bi0156557","article-title":"Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization\/mass spectrometric analysis","volume":"41","author":"Pike","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1195","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00018-007-6558-4","article-title":"Physiological functions of D-amino acid oxidases: from yeast to humans","volume":"64","author":"Pollegioni","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1200","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1177\/34.12.2878022","article-title":"Immunocytochemical localization of D-amino acid oxidase in the central clear matrix of rat kidney peroxisomes","volume":"34","author":"Usuda","year":"1986","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1205","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00726-012-1345-4","article-title":"Structure\u2013function relationships in human D-amino acid oxidase","volume":"43","author":"Sacchi","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1210","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1021\/ja9109049","article-title":"A proteome-wide perspective on peroxisome targeting signal 1(PTS1)-Pex5p affinities","volume":"132","author":"Ghosh","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0304-4165(91)90203-S","article-title":"D-aspartate oxidase, a peroxisomal enzyme in liver of rat and man","volume":"1073","author":"Van Veldhoven","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cne.10320","article-title":"Cellular and subcellular distribution of D-aspartate oxidase in human and rat brain","volume":"450","author":"Zaar","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnsyn.2014.00014","article-title":"Activity of D-amino acid oxidase is widespread in the human central nervous system","volume":"6","author":"Sasabe","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuroscience.2008.01.071","article-title":"Regulation of N-methyl-D-aspartate receptors by astrocytic D-serine","volume":"158","author":"Oliet","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1235","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/glia.20356","article-title":"Molecular determinants of D-serine-mediated gliotransmission: from release to function","volume":"54","author":"Oliet","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1240","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1073\/pnas.182412499","article-title":"Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia","volume":"99","author":"Chumakov","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mp.2009.99","article-title":"The neurobiology of D-amino acid oxidase and its involvement in schizophrenia","volume":"15","author":"Verrall","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2008.02.002","article-title":"Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia","volume":"101","author":"Madeira","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1255","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/j.1460-9568.2007.05769.x","article-title":"D-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia","volume":"26","author":"Verrall","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2006.10.010","article-title":"A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia","volume":"90","author":"Bendikov","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1265","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2174\/1381612811319140002","article-title":"D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy","volume":"19","author":"Sacchi","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1270","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.0914128107","article-title":"Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase","volume":"107","author":"Mitchell","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1275","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1073\/pnas.1114639109","article-title":"D-amino acid oxidase controls motoneuron degeneration through D-serine","volume":"109","author":"Sasabe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1280","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuron.2012.11.002","article-title":"Using whole-exome sequencing to identify inherited causes of autism","volume":"77","author":"Yu","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1285","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1177\/0883073811435507","article-title":"Association between peroxisomal biogenesis factor 7 and autism spectrum disorders in a Korean population","volume":"27","author":"Ro","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.plefa.2009.01.007","article-title":"Plasma fatty acid profiles in autism: a case\u2013control study","volume":"80","author":"Wiest","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.plefa.2004.03.008","article-title":"Essential fatty acids and phospholipase A2 in autistic spectrum disorders","volume":"71","author":"Bell","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1300","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/mgme.1999.2926","article-title":"Genotype\u2013phenotype correlations in disorders of peroxisome biogenesis","volume":"68","author":"Moser","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1305","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","article-title":"Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease","volume":"58","author":"Guan","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1310","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","article-title":"Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry","volume":"77","author":"Han","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1315","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-011-0836-9","article-title":"Peroxisomal alterations in Alzheimer's disease","volume":"122","author":"Kou","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1320","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2015.18","article-title":"Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects","volume":"27","author":"Wood","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3233\/JAD-2011-101608","article-title":"Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex","volume":"24","author":"Igarashi","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1330","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1471-4159.2010.07070.x","article-title":"Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease","volume":"116","author":"Grimm","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1335","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1023\/A:1011603916962","article-title":"Brain membrane phospholipid alterations in Alzheimer's disease","volume":"26","author":"Pettegrew","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1340","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1567205052772786","article-title":"Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease","volume":"2","author":"Han","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1345","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02531202","article-title":"Curvilinear regression course of human brain lipid composition changes with age","volume":"3","author":"Rouser","year":"1968","journal-title":"Lipids"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1350","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(95)00931-F","article-title":"Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain","volume":"698","author":"Ginsberg","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1355","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1194\/jlr.P700023-JLR200","article-title":"Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia","volume":"48","author":"Goodenowe","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1360","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1503\/jpn.090059","article-title":"Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients","volume":"35","author":"Wood","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12035-009-8091-y","article-title":"Studies on plasmalogen-selective phospholipase A2 in brain","volume":"41","author":"Farooqui","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1370","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fphys.2013.00168","article-title":"Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease","volume":"4","author":"Bennett","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1375","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3233\/JAD-142046","article-title":"Fatty acid profiles in demented patients: identification of hexacosanoic acid (c26:0) as a blood lipid biomarker of dementia","volume":"44","author":"Zarrouk","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012538","article-title":"Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease","volume":"5","author":"Astarita","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1385","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/exnr.1997.6750","article-title":"Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease","volume":"150","author":"Marcus","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1390","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3233\/JAD-2009-1199","article-title":"Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes","volume":"18","author":"Cimini","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1395","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-8-8","article-title":"Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease","volume":"8","author":"Fanelli","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1400","doi-asserted-by":"crossref","first-page":"41057","DOI":"10.1074\/jbc.M505160200","article-title":"Peroxisomal proliferation protects from beta-amyloid neurodegeneration","volume":"280","author":"Santos","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1405","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/156720509788486518","article-title":"Neuronal response of peroxisomal and peroxisome-related proteins to chronic and acute Abeta injury","volume":"6","author":"Cimini","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1410","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2012.08.086","article-title":"Inhibition of peroxisomal beta-oxidation by thioridazine increases the amount of VLCFAs and Abeta generation in the rat brain","volume":"528","author":"Shi","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1415","doi-asserted-by":"crossref","first-page":"141240","DOI":"10.1100\/2012\/141240","article-title":"Plasmalogens inhibit APP processing by directly affecting gamma-secretase activity in Alzheimer's disease","volume":"2012","author":"Rothhaar","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1420","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","article-title":"Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease","volume":"1801","author":"Han","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1425","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2011-111163","article-title":"Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type","volume":"29","author":"Lizard","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1430","first-page":"1","article-title":"The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts","volume":"20","author":"Mirsky","year":"1949","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1435","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.2174\/138161209789271799","article-title":"Insulin-degrading enzyme: structure\u2013function relationship and its possible roles in health and disease","volume":"15","author":"Fernandez-Gamba","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1440","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1073\/pnas.92.9.3859","article-title":"Degradation of the cleaved leader peptide of thiolase by a peroxisomal proteinase","volume":"92","author":"Authier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1445","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1210\/endo.138.8.5344","article-title":"Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation","volume":"138","author":"Chesneau","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1450","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1247\/csf.25.309","article-title":"Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins","volume":"25","author":"Morita","year":"2000","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1455","doi-asserted-by":"crossref","first-page":"22599","DOI":"10.1016\/S0021-9258(17)31688-5","article-title":"Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line","volume":"269","author":"Kuo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1460","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/BJ20041081","article-title":"Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria","volume":"383","author":"Leissring","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1465","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/153537020523000706","article-title":"Androgen- and estrogen-dependent regulation of insulin-degrading enzyme in subcellular fractions of rat prostate and uterus","volume":"230","author":"Udrisar","year":"2005","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1470","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-3-22","article-title":"Detergent resistant membrane-associated IDE in brain tissue and cultured cells: relevance to Abeta and insulin degradation","volume":"3","author":"Bulloj","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1475","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1480","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1007\/s00018-008-8112-4","article-title":"Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin","volume":"65","author":"Malito","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1485","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer's disease to chromosome 10q","volume":"290","author":"Bertram","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1490","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2013.01.051","article-title":"Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's disease","volume":"541","author":"Zhang","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1495","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","article-title":"Genetics of Alzheimer's disease","volume":"87","author":"Chouraki","year":"2014","journal-title":"Adv. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1500","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1505","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1510","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1515","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1515\/CCLM.2009.205","article-title":"Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease","volume":"47","author":"Dragonas","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1520","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.psychres.2012.02.019","article-title":"Impaired plasmalogens in patients with schizophrenia","volume":"198","author":"Kaddurah-Daouk","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1525","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.schres.2014.11.032","article-title":"Dysfunctional plasmalogen dynamics in the plasma and platelets of patients with schizophrenia","volume":"161","author":"Wood","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1530","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(00)02205-8","article-title":"Phospholipid composition and levels are altered in Down syndrome brain","volume":"867","author":"Murphy","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1535","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1017\/S0007114514003298","article-title":"Erythrocyte phospholipid molecular species and fatty acids of Down syndrome children compared with non-affected siblings","volume":"113","author":"Bueno","year":"2014","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1540","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-511X-10-102","article-title":"Targeted metabolomic analyses of cellular models of Pelizaeus\u2013Merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction","volume":"10","author":"Wood","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1545","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2014.01.005","article-title":"Gaucher disease: plasmalogen levels in relation to primary lipid abnormalities and oxidative stress","volume":"53","author":"Moraitou","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1550","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00710270","article-title":"Low erythrocyte plasmalogen and plasma docosahexaenoic acid (DHA) in juvenile neuronal ceroid-lipofuscinosis (JNCL)","volume":"16","author":"Kohlschutter","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1555","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-2012-110629","article-title":"Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease","volume":"29","author":"Cunnane","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1560","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jnr.22246","article-title":"alpha-Synuclein abnormalities in mouse models of peroxisome biogenesis disorders","volume":"88","author":"Yakunin","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.06.059","article-title":"Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment","volume":"1022","author":"Singh","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1570","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/1352458513505691","article-title":"Reductions in neuronal peroxisomes in multiple sclerosis grey matter","volume":"20","author":"Gray","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1575","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12883-015-0411-4","article-title":"Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study","volume":"15","author":"Senanayake","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1580","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/ng1297-445","article-title":"Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders","volume":"17","author":"Reuber","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1585","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jmg.36.10.779","article-title":"Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders","volume":"36","author":"Shimozawa","year":"1999","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1590","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/303071","article-title":"Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G","volume":"67","author":"Muntau","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1595","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ng0295-115","article-title":"Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders","volume":"9","author":"Dodt","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1600","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1002\/j.1460-2075.1996.tb00654.x","article-title":"The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor","volume":"15","author":"Yahraus","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1605","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s100380170078","article-title":"The peroxin Pex6p gene is impaired in peroxisomal biogenesis disorders of complementation group 6","volume":"46","author":"Matsumoto","year":"2001","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1610","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/301963","article-title":"Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders","volume":"63","author":"Warren","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1615","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ng0497-385","article-title":"Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders","volume":"15","author":"Chang","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1620","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1212\/01.WNL.0000127576.26352.D1","article-title":"Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder","volume":"62","author":"Gootjes","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1625","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/hmg\/8.6.1077","article-title":"Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders","volume":"8","author":"Shimozawa","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1630","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1086\/302534","article-title":"PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders","volume":"65","author":"Liu","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1635","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/humu.20032","article-title":"Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene","volume":"23","author":"Shimozawa","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1640","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1086\/302161","article-title":"Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D","volume":"63","author":"Honsho","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1645","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1073\/pnas.96.5.2116","article-title":"Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly","volume":"96","author":"Matsuzono","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1650","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/377004","article-title":"Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype\u2013phenotype correlation","volume":"73","author":"Matsumoto","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1655","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jmedgenet-2012-100778","article-title":"A novel defect of peroxisome division due to a homozygous non-sense mutation in the PEX11beta gene","volume":"49","author":"Ebberink","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1660","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jmedgenet-2012-100899","article-title":"First PEX11beta patient extends spectrum of peroxisomal biogenesis disorder phenotypes","volume":"49","author":"Thoms","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1665","first-page":"422","article-title":"A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy)","volume":"42","author":"Poll-The","year":"1988","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1670","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI113956","article-title":"Peroxisomal bifunctional enzyme deficiency","volume":"83","author":"Watkins","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1675","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/hmg\/ddu448","article-title":"A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3","volume":"24","author":"Ferdinandusse","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1680","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1097-185","article-title":"Identification of PAHX, a Refsum disease gene","volume":"17","author":"Mihalik","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1685","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng1147","article-title":"Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT","volume":"34","author":"Carlton","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1690","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0014-5793(86)80563-4","article-title":"Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I","volume":"201","author":"Danpure","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1695","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00201829","article-title":"Acatalasemia","volume":"86","author":"Ogata","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbamcr.2015.12.005_bb1700","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ng0196-52","article-title":"Sjogren\u2013Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene","volume":"12","author":"De Laurenzi","year":"1996","journal-title":"Nat. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488915004267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488915004267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T03:53:34Z","timestamp":1718250814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488915004267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":340,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0167488915004267"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2015.12.005","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisomes in brain development and function","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2015.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}